药物再评价_药药网

名称：名称(英)：

药物再评价19557个记录

药物再评价

名称

名称(英)

【氨基酸营养防治少肌症】

[Amino Acid Nutrition in the Prevention and Treatment of Sarcopenia]

乳果糖和/或利福昔明对肝性脑病的长期治疗：证据回顾

Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence

硫唑嘌呤治疗炎症性肠病患者基因型筛查和治疗药物监测的成本效益分析：使用真实世界数据的中国医疗保健视角

Cost-effectiveness analysis of genotype screening and therapeutic drug monitoring in patients with inflammatory bowel disease treated with azathioprine therapy: a Chinese healthcare perspective using real-world data

针对血吸虫病的疫苗接种或大规模给药：假设的成本效益模型比较

Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison

β-羟基-β-甲基丁酸补充剂和健康和肌肉萎缩条件下的骨骼肌

Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions

海藻酸盐在给药中的现状

Current Status of Alginate in Drug Delivery

药价综合改革成效评估——以西部石河子市为例

Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China

使用描述做法和老年人潜在不适当处方标准的筛选工具来减少老年人的伤害和可预防的药物不良事件

Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults

控制口腔微生物生物膜的新方法

Novel Approaches to the Control of Oral Microbial Biofilms

抗体-药物偶联物 (ADC) 的有效性：体外和体内研究的结果

Effectiveness of Antibody-Drug Conjugate (ADC): Results of In Vitro and In Vivo Studies

结肠癌干细胞：治疗结直肠癌的潜在靶点

Colon cancer stem cells: Potential target for the treatment of colorectal cancer

非典型抗精神病药物在心境障碍中的作用机制

Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders

二十碳五烯酸 (EPA) 和二十二碳六烯酸 (DHA) 对肌肉损伤和功能的影响

Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function

绿茶提取物协同增强抗再吸收药物对大鼠模型卵巢切除术引起的骨质疏松症的治疗效果

Green tea extract synergistically enhances the effectiveness of an antiresorptive drug on management of osteoporosis induced by ovariectomy in a rat model

传统医药协同效应如何受益于网络药理学？

How Can Synergism of Traditional Medicines Benefit from Network Pharmacology?

比较制造商提交的和泛加拿大肿瘤药物审查重新分析新肿瘤药物的增量成本效益比

Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology Drugs

将成本效益分析纳入处方决策是否会促进药物获取公平？

Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity?

抗凝：更新的门诊管理指南

Anticoagulation: Updated Guidelines for Outpatient Management

生命末日姑息性药物治疗的安全性和有效性——系统文献综述

Safety and Effectiveness of Palliative Drug Treatment in the Last Days of Life-A Systematic Literature Review

宫缩药物预防产后出血：一项网络荟萃分析

Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis

最新招商产品更多>>

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：